Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 4
1994 1
1995 1
1997 1
1998 3
1999 1
2000 5
2001 3
2002 1
2004 2
2006 4
2008 2
2009 3
2010 6
2011 9
2012 8
2013 6
2014 11
2015 10
2016 16
2017 12
2018 11
2019 8
2020 18
2021 15
2022 18
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
Treatment for secondary hyperparathyroidism focusing on parathyroidectomy.
Hiramitsu T, Hasegawa Y, Futamura K, Okada M, Goto N, Narumi S, Watarai Y, Tominaga Y, Ichimori T. Hiramitsu T, et al. Among authors: watarai y. Front Endocrinol (Lausanne). 2023 Apr 20;14:1169793. doi: 10.3389/fendo.2023.1169793. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152972 Free PMC article. Review.
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. Among authors: watarai y. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.
Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J; TRANSFORM investigators. Berger SP, et al. Among authors: watarai y. Am J Transplant. 2019 Nov;19(11):3018-3034. doi: 10.1111/ajt.15480. Epub 2019 Jul 1. Am J Transplant. 2019. PMID: 31152476 Free article. Clinical Trial.
Persistent hyperparathyroidism after preemptive kidney transplantation.
Okada M, Sato T, Hasegawa Y, Futamura K, Hiramitsu T, Ichimori T, Goto N, Narumi S, Takeda A, Watarai Y. Okada M, et al. Among authors: watarai y. Clin Exp Nephrol. 2023 Oct;27(10):882-889. doi: 10.1007/s10157-023-02371-9. Epub 2023 Jun 23. Clin Exp Nephrol. 2023. PMID: 37351681 Free PMC article.
Current surgical training: simultaneous training in open and laparoscopic surgery.
Kano N, Takeshi A, Kusanagi H, Watarai Y, Mike M, Yamada S, Mishima O, Uwafuji S, Kitagawa M, Watanabe H, Kitahama S, Matsuda S, Endo S, Gremillion D. Kano N, et al. Among authors: watarai y. Surg Endosc. 2010 Dec;24(12):2927-9. doi: 10.1007/s00464-010-1238-0. Surg Endosc. 2010. PMID: 20669034 Free PMC article. No abstract available.
166 results